title: Experimental rhinovirus infection in volunteers.
abstract: Experimental viral disease studies in volunteers have clarified many aspects of the pathogenesis of human viral disease. Recently, interest has focused on rhinovirus-associated asthma exacerbations, and new volunteer studies have suggested that airway responsiveness (AR) is enhanced during a cold. For scientific, ethical and safety reasons, it is important to use validated methods for the preparation of a virus inoculum and that the particular virological characteristics and host responses should not be altered. We have prepared a new human rhinovirus (HRV) inoculum using recent guidelines and assessed whether disease characteristics (for example, severity of colds or changes in AR) were retained. Studies were conducted in 25 clinically healthy volunteers using a validated HRV inoculum in the first 17 and a new inoculum in the subsequent eight subjects. Severity of cold symptoms, nasal wash albumin levels and airway responsiveness were measured, and the new inoculum was prepared from nasal washes obtained during the cold. The new inoculum was tested using standard virological and serological techniques, as well as a polymerase chain reaction for Mycoplasma pneumoniae. No contaminating viruses or organisms were detected and the methods suggested were workable. Good clinical colds developed in 20 of the 25 subjects and median symptom scores were similar in the validated and new inoculum groups (18 and 17.5, respectively; p=0.19). All subjects shed virus, and there were no differences noted in viral culture scores, nasal wash albumin and rates of seroconversion in the two groups. Although airway responsiveness increased in both groups (p=0.02 and p=0.05), the degree of change was similar. We have performed experimental rhinovirus infection studies and demonstrated similar clinical disease in two inoculum groups. Amplified airway responsiveness was induced; continuing studies will define the mechanisms and suggest modes of treatment.
authors.affiliation: Immunopharmacology Group, University Medicine, Southampton General Hospital, UK.
authors.forename: P G
authors.initials: PG
authors.lastname: Bardin
authors.forename: G
authors.initials: G
authors.lastname: Sanderson
authors.forename: B S
authors.initials: BS
authors.lastname: Robinson
authors.forename: S T
authors.initials: ST
authors.lastname: Holgate
authors.forename: D A
authors.initials: DA
authors.lastname: Tyrrell
mesh_terms: D000328:Adult; D000418:Albumins / Q000032:analysis; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001985:Bronchial Provocation Tests; D006801:Humans; D051379:Mice; D008875:Middle Aged; D009177:Mycoplasma pneumoniae / Q000302:isolation & purification; D017817:Nasal Lavage Fluid / Q000737:chemistry / Q000382:microbiology / Q000821:virology; D010850:Picornaviridae Infections / Q000503:physiopathology* / Q000821:virology; D012229:Rhinovirus / Q000276:immunology
chemical_list: D000418:Albumins; D000914:Antibodies, Viral